MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

MMJ Recs

OCTOBER 31, 2023

The Mountain State’s journey to legalizing medical marijuana has been a transformative one, and it marks a new era for MMJ access in West Virginia. This act has opened the doors to legal MMJ access for eligible patients, offering an alternative approach to managing their health.

Access 52

Access Programs Patients Dispensary 52

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

Veriheal

JUNE 21, 2023

There will also be measures put in place to control therapeutic access to psilocybin while awaiting federal reform. If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments.

Access 97

Access Legalization Research and Development Legislation 97

Veriheal

MARCH 1, 2022

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. What is Psilocybin?

Therapy 98

Therapy Programs Microdosing Medicine 98

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Timeline of Medicinal Legalization in Canada. The changes to the FDR and CDSA do not outright legalize MDMA or psilocybin for medicinal use.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Veriheal

JULY 21, 2022

This month, patients will no longer require a medical cannabis card to participate in Virginia’s medical cannabis program. So this is a huge improvement and will make the process much easier for those looking to access medical cannabis in Virginia,” said Jenn Michelle Pedini, Executive Director for Virginia NORML.

Access 104

Access Dispensary Patients Programs 104

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Veriheal

NOVEMBER 11, 2021

Before Proposition 64 was officially enacted into state law, California’s medical cannabis consumers were generously served by a range of successful and well-executed compassionate care programs. A Collaborative Effort To Increase Cannabis Access. “Cannabis is medicine. Gavin Newsom in October 2019.

Programs 98

Programs Patients Access Medicine 98

MMJ Recs

MAY 29, 2024

The perception and legalization of marijuana for medicinal use have undergone a significant shift across the United States. Pennsylvania, among many states, has embraced this change by implementing a medical marijuana program. Image by Iñaki del Olmo on Unsplash.

Marijuana 52

Marijuana Programs Patients Conditions 52

Cannabis Law Report

JULY 20, 2021

Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry. With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Americans for Safe Access

JULY 29, 2020

Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program, and users of cannabis medicine can be found in either group. Of course having the conversation about cannabis can be complicated, intimidating and nerve racking.

Programs 169

Programs Therapy Medicine Patients 169

Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Office of Medicinal Cannabis, Department of Health, Melbourne, VIC 3000, Australia.

Medicine 59

Medicine Safety Policy Treatment 59

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. But even with the TTOR’s focus on prevention, treatment, and recovery, illicit operations continue to wreak havoc.

Programs 52

Programs Chronic Pain Treatment Conditions 52

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 261

Law Patients Access Oil 261

MMJ Recs

JANUARY 15, 2024

Today we’re here to tell you all you need to know about accessing and using medical marijuana in New Jersey! Governed by strict regulations, the program aims to provide patients with safe access to medicinal cannabis while maintaining a structured framework.

Chronic Pain 52

Chronic Pain Marijuana Programs Conditions 52

Veriheal

APRIL 1, 2024

Cannabis is not legal in North Carolina for medicinal or recreational purposes yet, but one group has their own rules–the Eastern Band of Cherokee Indians (EBCI). When North Carolina launches its own medical cannabis program, all qualified state residents will be able to purchase products. The Great Smoky Cannabis Co.

Dispensary 106

Dispensary Chronic Pain Medicine History 106

MMJ Recs

MARCH 8, 2024

Delving into Missouri’s medical marijuana program, this article offers an in-depth exploration of the costs associated with obtaining a medical card in Missouri. From understanding the program’s history and regulations to navigating the application process, we provide a comprehensive overview.

Access 52

Access Programs Patients Dispensary 52

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

MARCH 19, 2022

publishers announces the launch of Psychedelic Medicine , an influential and dynamic peer-reviewed journal supporting the growing influential research and clinical applications in this pivotal field. For further information or submission inquiries about Psychedelic Medicine , please contact us. Mary Ann Liebert Inc.,

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

JUNE 29, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Texas Original Compassionate Cultivation (TOCC), Texas’ leading medical cannabis provider, says it will continue to advocate for an opioid alternative program as the opioid epidemic grips Texas. The Nucleus One report also explains how medical cannabis is a proven alternative to opioids.

Treatment 75

Treatment Cultivation Chronic Pain Programs 75

Veriheal

JULY 2, 2020

Louisiana has had a medical cannabis program for many years. However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. The Bill as Passed. Now that the bill has been signed, as of August 1 st.,

Banking 52

Banking Programs Therapy Conditions 52

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

MMJ Recs

FEBRUARY 16, 2024

This article delves into the current status of medical marijuana in Texas, exploring the laws, regulations, qualifying conditions, and the overall framework that shapes the use of cannabis for medicinal purposes in the Lone Star State.

Legalization 52

Legalization Marijuana Dispensary Conditions 52

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Patients, and their treatment, therefore, are the priority.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

SpeedWeed

APRIL 29, 2021

Texas passed a bill through the House of Representatives today, titled HB 1535, that would expand the state’s medical cannabis program to cover more conditions, and therefore, service more people who rely on the plant. percent to 5 percent, meaning that patients in Texas would now actually be able to access medicine with THC.

Programs 52

Programs Chronic Pain Access Patients 52

Cannabis Law Report

JUNE 17, 2021

goodblend™ Texas , a retail brand of Parallel , one of the nation’s largest privately-held multi-state cannabis operators, today announced the launch of the first cannabinol (CBN) products for patients registered in the Texas Compassionate Use Program. goodblend™ Texas, a retail brand of Parallel.

Patients 97

Patients Programs Sleep Retail 97

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

Cannabis Law Report

JULY 29, 2021

These assets include 5 addiction treatment clinics across the province of Alberta that have conducted over 35,000 patient visits during the past 12 months. Each clinic employs a highly educated and specialized team of dedicated physicians, nurses and therapists working in unison with patients to ensure treatment goals are achieved.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

MMJ Recs

JANUARY 10, 2024

Benefits of Medical Marijuana for Pain Relief The medicinal properties of marijuana, particularly its cannabinoids, have been harnessed for centuries. Medical marijuana is increasingly recognized for its ability to offer relief in conditions such as neuropathic pain, arthritis, and pain associated with certain medical treatments.

Chronic Pain 98

Chronic Pain Patients Cannabinoids Treatment 98

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets.

Oil 98

Oil Patients Access THC 98

NORML

MAY 26, 2020

Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 253

Clinical Trials Chronic Pain Cannabinoids Patients 253

MMJ Recs

DECEMBER 17, 2023

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.

Law 52

Law Dispensary Clinical Trials Programs 52

Cannabis Law Report

JULY 8, 2021

Many Australian consumers of medicinal cannabis access products that contain delta-9-tetrahydrocannabinol, better known as THC, which is a controlled drug under the Australian Poisons Standard, which provides a uniform approach to control the availability and accessibility of substances that can be used as ingredients in medicine. ‘A

Medicine 98

Medicine Research and Development Safety THC 98

Cannabis Law Report

JULY 13, 2022

A legislative panel on Tuesday listened to advocates who hope to broaden the scope of medical treatment and research assisted by psilocybin, the psychedelic active ingredient in certain mushrooms. Oregon is so far the only state to legalize the therapeutic use of psilocybin.

Therapy 52

Therapy Legislation Access Decriminalization 52